Light Switch Bio
Light Switch Bio (LSB) is developing a method to avoid the off-target side effects of drugs by adapting them into pro-drugs that allow for laser-guided control of their activity.
Light Switch Bio (LSB) is developing a method to avoid the off-target side effects of drugs by adapting them into pro-drugs that allow for laser-guided control of their activity.
Rapid Forensic Cell Typing’s (RFCT) mission is to revolutionize criminal investigations with a SaaS platform that enables rapid identification and prioritization of forensic evidence.
Atticus Pharma has developed a unique, patented, sustained-release system for delivering therapeutics directly through the skin.
OrthoPreserve, Inc. is creating an artificial meniscus implant that will relieve chronic knee pain and prevent arthritis development for patients with knee injuries involving the meniscus.
Vizma Life Sciences develops innovative devices that make metabolic MRI more affordable and more accessible for early disease detection and treatment monitoring.
Oncoustics creates advanced AI solutions for low cost, non-invasive surveillance, diagnostics, and treatment monitoring of diseases with high unmet clinical needs.
KeViRx is transforming patient care for acute lung injury (ALI) through the development of innovative small molecule drugs.